Smartwatch detection of atrial flutter and atrial fibrillation: when the apple falls far from the tree - case report

Consumer wearables are increasingly used to document palpitations, but their algorithms are almost exclusively validated for atrial fibrillation (AF). We report a 70-year-old man with recurrent palpitations, no prior cardiovascular history, and controlled hypertension. A single-lead Apple Watch ECG classified sinus rhythm at 75 bpm, while a same-day 12-lead ECG revealed typical atrial flutter with sawtooth waves and regular atrioventricular conduction. After adequate anticoagulation, the patient underwent successful electrical cardioversion with 120 J and remains in stable sinus rhythm. This case highlights that AF-validated smartwatch algorithms may miss other supraventricular arrhythmias, particularly with regular ventricular response. Smartwatches can aid AF screening and symptom capture, but persistent symptoms require confirmation with standard 12-lead ECG. Future work should prioritize algorithm refinement and rigorous, post-market validation beyond AF to ensure that consumer devices transition from wellness tools to clinically reliable instruments for arrhythmia management. When a smartwatch says “normal” but the heart rhythm is not: Smartwatches like the Apple Watch can record a simple heart tracing and warn users about atrial fibrillation, a common irregular heart rhythm linked to stroke risk. These devices work well when the heartbeat is irregular, but they are not designed to detect all rhythm problems. In this report, a patient had palpitations and shortness of breath. His smartwatch showed a “normal rhythm.” On the same day, a standard hospital ECG showed a different rhythm problem called atrial flutter. Although the heartbeat was regular, this condition can carry a stroke risk similar to atrial fibrillation and often requires medical treatment. This case shows an important limitation of current smartwatch technology. When the heartbeat is regular, the device may miss certain abnormal rhythms and falsely reassure the user. This may delay medical evaluation, even when symptoms are present. Knowing these limits can help clinicians and patients use smartwatch recordings more safely. Ongoing symptoms should always be checked with a standard medical ECG, even if the smartwatch result appears normal. Future smartwatch software should aim to detect a wider range of rhythm problems and better explain what the device can and cannot identify.